Interplay between miRNAs and human diseases
P Paul, A Chakraborty, D Sarkar… - Journal of cellular …, 2018 - Wiley Online Library
MicroRNAs (miRNAs) are endogenous, non‐coding RNAs, which have evoked a great deal
of interest due to their importance in many aspects of homeostasis and diseases …
of interest due to their importance in many aspects of homeostasis and diseases …
Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives
Recent research has demonstrated that the non-coding genome plays a key role in genetic
programming and gene regulation during development as well as in health and …
programming and gene regulation during development as well as in health and …
[HTML][HTML] Application of the nano-drug delivery system in treatment of cardiovascular diseases
Y Deng, X Zhang, H Shen, Q He, Z Wu… - … in bioengineering and …, 2020 - frontiersin.org
Cardiovascular diseases (CVDs) have become a serious threat to human life and health.
Though many drugs acting via different mechanism of action are available in the market as …
Though many drugs acting via different mechanism of action are available in the market as …
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
The onset of heart failure is typically preceded by cardiac hypertrophy, a response of the
heart to increased workload, a cardiac insult such as a heart attack or genetic mutation …
heart to increased workload, a cardiac insult such as a heart attack or genetic mutation …
Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling
I Karakikes, AH Chaanine, S Kang… - Journal of the …, 2013 - Am Heart Assoc
Background Micro RNA s (mi RNA s) play a key role in the development of heart failure, and
recent studies have shown that the muscle‐specific miR‐1 is a key regulator of cardiac …
recent studies have shown that the muscle‐specific miR‐1 is a key regulator of cardiac …
Essential role for premature senescence of myofibroblasts in myocardial fibrosis
K Meyer, B Hodwin, D Ramanujam… - Journal of the American …, 2016 - jacc.org
Background: Fibrosis is a hallmark of many myocardial pathologies and contributes to
distorted organ architecture and function. Recent studies have identified premature …
distorted organ architecture and function. Recent studies have identified premature …
[HTML][HTML] Altered myocardial calcium cycling and energetics in heart failure—a rational approach for disease treatment
PA Gorski, DK Ceholski, RJ Hajjar - Cell metabolism, 2015 - cell.com
Cardiomyocyte function depends on coordinated movements of calcium into and out of the
cell and the proper delivery of ATP to energy-utilizing enzymes. Defects in calcium-handling …
cell and the proper delivery of ATP to energy-utilizing enzymes. Defects in calcium-handling …
MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors
J Ganesan, D Ramanujam, Y Sassi, A Ahles… - Circulation, 2013 - Am Heart Assoc
Background—Several microRNAs (miRs) have been shown to regulate gene expression in
the heart, and dysregulation of their expression has been linked to cardiac disease. miR-378 …
the heart, and dysregulation of their expression has been linked to cardiac disease. miR-378 …
Structural insight into the unique properties of adeno-associated virus serotype 9
Adeno-associated virus serotype 9 (AAV9) has enhanced capsid-associated tropism for
cardiac muscle and the ability to cross the blood-brain barrier compared to other AAV …
cardiac muscle and the ability to cross the blood-brain barrier compared to other AAV …
[HTML][HTML] Emerging roles of circRNAs in the pathological process of myocardial infarction
ZJ Wen, H Xin, YC Wang, HW Liu, YY Gao… - … Therapy-Nucleic Acids, 2021 - cell.com
Myocardial infarction (MI) is defined as cardiomyocyte death in a clinical context consistent
with ischemic insult. MI remains one of the leading causes of morbidity and mortality …
with ischemic insult. MI remains one of the leading causes of morbidity and mortality …